Graduate School of Nanobioscience, Yokohama City University, 22-2 Seto, Kanazawa-ku, Yokohama 236-0027, Japan.
Graduate School of Chemical Sciences and Engineering, Hokkaido University, Kita 13 Nishi 8, Kita-ku, Sapporo 060-8628, Japan.
Inorg Chem. 2024 Jul 29;63(30):13972-13979. doi: 10.1021/acs.inorgchem.4c01414. Epub 2024 Jul 12.
Here, we report a photodynamic therapy (PDT) photosensitizer of NCN-coordinated Pt(II) complexes: [Pt(L)(solv)] (HL = 1,3-(2-dipyridyl)benzene) and [Pt(L)]@HSA, which is the Pt(II) complex encapsulated in human serum albumin (HSA). The quantum yield of singlet oxygen production for [Pt(L)(solv)] is more than 50%, while that for [Pt(L)]@HSA is much lower. Photoimages of human umbilical vein endothelial cells (HUVECs) treated with the Pt(II) complexes suggest that [Pt(L)(solv)] is delocalized in the entire cell after the fast uptake by diffusion and [Pt(L)]@HSA is taken up by endocytosis and localized on organelles and the cell membrane. [Pt(L)(solv)] shows high photocytotoxicity for HUVECs, while [Pt(L)]@HSA does not show photocytotoxicity.
在这里,我们报道了一种 NCN 配位的 Pt(II) 配合物的光动力治疗(PDT)光敏剂:[Pt(L)(solv)](HL = 1,3-(2-二吡啶基)苯)和 [Pt(L)]@HSA,这是一种封装在人血清白蛋白(HSA)中的 Pt(II) 配合物。[Pt(L)(solv)] 产生单线态氧的量子产率超过 50%,而 [Pt(L)]@HSA 的量子产率则低得多。用 Pt(II) 配合物处理的人脐静脉内皮细胞(HUVEC)的光图像表明,[Pt(L)(solv)] 通过扩散快速摄取后在整个细胞中扩散,而 [Pt(L)]@HSA 通过内吞作用摄取并定位于细胞器和细胞膜上。[Pt(L)(solv)] 对 HUVEC 表现出高的光细胞毒性,而 [Pt(L)]@HSA 则没有表现出光细胞毒性。